Skip to main content
Caplight Logo









BiovelocITA

BiovelocITA

Milan, Lombardybiovelocita.com

Overview

BiovelocITA is the first biotech accelerator in Italy, founded in 2015 by Silvano Spinelli, Gabriella Camboni, and Sofinnova Partners. It operates as a company builder, providing financial resources and hands-on management to accelerate early-stage, innovative biotech projects and transform them into successful companies. The firm supports projects from proof-of-concept to clinical phases, focusing on areas like rare genetic diseases, diabetes, and oncology.

Portfolio Companies

2

Investments

BiovelocITA investments
CompanyDateStageLead
Alia TherapeuticsJun 2021SeedCo-investor
Alia TherapeuticsApr 2019SeedLead
Alia TherapeuticsOct 2018AcceleratorCo-investor
EntheraJul 2018SeedCo-investor
EntheraNov 2016SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMilan, Lombardy
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?